10x Genomics, Inc. TXG
10x Genomics, Inc. statistics & valuation
Market cap$4.7B
P / S7.3×
P / B5.9×
P / FCF35.9×
Net margin-6.8%
Return on equity-5.5%
FCF margin20.2%
Return on capital-6.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 69.1% | 67.9% | 66.2% | 76.7% | 84.9% | 80.4% | 75.2% | 80.4% |
| Operating margin | -9.5% | -31.9% | -42.9% | -32.5% | -10.7% | -178.7% | -12.4% | -75.7% |
| Net margin | -6.8% | -29.9% | -41.2% | -32.1% | -11.9% | -181.6% | -12.7% | -76.9% |
| FCF margin | 20.2% | -0.9% | -10.3% | -32.0% | -25.0% | -85.2% | -3.3% | -56.5% |
| Return on assets | -4.2% | -19.9% | -26.4% | -16.1% | -5.7% | -58.4% | -5.2% | -90.5% |
| Return on equity | -5.5% | -25.7% | -34.4% | -20.6% | -7.1% | -73.4% | -7.4% | 51.1% |
| Debt / equity | — | — | — | — | — | 0.00× | 0.07× | -0.12× |
| Current ratio | 4.46 | 4.97 | 4.69 | 4.85 | 6.77 | 6.56 | 7.63 | 3.28 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.